Q2 FY2026 · ended Jun 30, 2026 · Revenue $18.99M, +28.8% YoY · Filed Aug 18, 2026
Cosmos Health Inc. (COSM) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $19.0 million and a net loss of $6.1 million. Free cash flow was -$1.8 million. As of Jun 30, 2026 it held $1.8 million in cash and investments and $3.8 million in total debt.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- COSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Thessaloniki, Greece
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1474167
- Former names
- Cosmos Holdings Inc. (until Dec 19, 2022); PRIME ESTATES & DEVELOPMENTS INC (until Jan 3, 2014)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $19.0M | $17.9M | $19.7M | $17.1M | $14.7M |
| Operating income | -$2.9M | -$2.2M | -$11.4M | -$1.8M | -$2.6M |
| Net income | -$6.1M | -$2.8M | -$10.1M | -$5.4M | -$2.8M |
| Diluted EPS | -$0.10 | -$0.06 | -$0.28 | -$0.17 | -$0.10 |
| Operating cash flow | -$1.7M | -$1.1M | -$4.6M | -$2.5M | -$1.2M |
| Free cash flow | -$1.8M | -$1.1M | -$4.6M | -$2.5M | -$1.2M |
| Total assets | $61.5M | $62.4M | $65.5M | $69.5M | $61.8M |
| Total liabilities | $40.8M | $42.5M | $47.1M | $46.4M | $35.6M |
| Stockholders' equity | $20.7M | $19.8M | $18.4M | $23.1M | $26.2M |
| Cash and investments | $1.8M | $548,927 | $761,832 | $922,619 | $30,266 |
| Total debt | $3.8M | $4.1M | $4.4M | $6.0M | $5.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 22, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 20, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 18, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jul 16, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 6, 2026 | Jun 30, 2026 |
All 636 Cosmos Health Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.